Drug Search Results
More Filters [+]

Lenomorelin

Alternative Names: lenomorelin
Latest Update: 2024-12-03
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Large Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Linkopings Universitet
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Lenomorelin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Stroke

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

2024-515705-26-00

P2

Unknown Status

Stroke

2026-04-30

Recent News Events

Date

Type

Title